A Worsening Problem in ALS: Insurance Barriers Between Drug Approvals and Patient Access

Authors

DOI:

https://doi.org/10.17161/rrnmf.v5i1.21232

Keywords:

Riluzole, Edaravone, Taurursodiol, Phenylbutyrate

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Downloads

Published

2024-03-01

Issue

Section

New Discoveries and Original Research

How to Cite

Bedlack, R., Heitzman, D., & Shefner , J. (2024). A Worsening Problem in ALS: Insurance Barriers Between Drug Approvals and Patient Access. RRNMF Neuromuscular Journal, 5(1). https://doi.org/10.17161/rrnmf.v5i1.21232